Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
Taiwan
· Delayed Price · Currency is TWD 175.50
+0.50 (0.29%)
Feb 14, 2025, 9:00 AM CST
TPEX:6712 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 13, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Market Capitalization | 15,211 | 14,338 | 15,025 | 13,013 | 9,856 | 9,043 | Upgrade
|
| Market Cap Growth | -0.23% | -4.57% | 15.46% | 32.03% | 8.99% | 59.89% | Upgrade
|
| Enterprise Value | 14,578 | 13,324 | 13,889 | 11,764 | 9,488 | 8,387 | Upgrade
|
| Last Close Price | 186.50 | 172.46 | 175.17 | 148.22 | 123.93 | 113.71 | Upgrade
|
| PE Ratio | 59.30 | 26.58 | 74.86 | 35.21 | - | - | Upgrade
|
| PS Ratio | 17.85 | 18.91 | 23.94 | 29.65 | 139.61 | 835.88 | Upgrade
|
| PB Ratio | 9.51 | 7.78 | 8.38 | 6.86 | 12.62 | 10.69 | Upgrade
|
| P/TBV Ratio | 9.55 | 7.82 | 8.44 | 6.90 | 12.79 | 10.81 | Upgrade
|
| P/FCF Ratio | 36.96 | 34.47 | 47.55 | 97.32 | - | - | Upgrade
|
| P/OCF Ratio | 35.99 | 34.00 | 47.07 | 95.90 | - | - | Upgrade
|
| EV/Sales Ratio | 17.26 | 17.57 | 22.13 | 26.81 | 134.40 | 775.20 | Upgrade
|
| EV/EBITDA Ratio | 35.65 | 37.25 | 45.20 | 83.16 | - | - | Upgrade
|
| EV/EBIT Ratio | 38.50 | 39.45 | 48.94 | 101.24 | - | - | Upgrade
|
| EV/FCF Ratio | 35.42 | 32.04 | 43.95 | 87.99 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.02 | 0.06 | 0.04 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.02 | 0.06 | 0.23 | - | - | Upgrade
|
| Debt / FCF Ratio | 0.01 | 0.01 | 0.06 | 0.26 | - | - | Upgrade
|
| Asset Turnover | 0.44 | 0.37 | 0.31 | 0.30 | 0.08 | 0.01 | Upgrade
|
| Inventory Turnover | 2.75 | 3.48 | 2.94 | 4.19 | 3.52 | - | Upgrade
|
| Quick Ratio | 2.90 | 6.20 | 8.28 | 14.58 | 10.73 | 20.73 | Upgrade
|
| Current Ratio | 3.31 | 6.57 | 8.89 | 15.20 | 11.87 | 21.68 | Upgrade
|
| Return on Equity (ROE) | 15.29% | 29.68% | 10.88% | 27.60% | -13.13% | -10.60% | Upgrade
|
| Return on Assets (ROA) | 12.40% | 10.43% | 8.88% | 5.04% | -11.10% | -9.12% | Upgrade
|
| Return on Capital (ROIC) | 14.18% | 11.54% | 9.48% | 5.27% | -11.51% | -9.34% | Upgrade
|
| Return on Capital Employed (ROCE) | 23.60% | 18.31% | 15.68% | 6.03% | - | - | Upgrade
|
| Earnings Yield | 1.67% | 3.76% | 1.34% | 2.84% | -1.08% | -1.04% | Upgrade
|
| FCF Yield | 2.71% | 2.90% | 2.10% | 1.03% | -2.00% | -1.40% | Upgrade
|
| Dividend Yield | 2.92% | 3.16% | 0.94% | 2.54% | - | - | Upgrade
|
| Payout Ratio | 173.02% | 25.27% | 154.19% | - | - | - | Upgrade
|
| Buyback Yield / Dilution | 1.91% | 0.84% | -0.15% | -11.01% | -0.09% | -6.37% | Upgrade
|
| Total Shareholder Return | 4.83% | 4.01% | 0.80% | -8.47% | -0.09% | -6.37% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.